The merger between the two companies will create a new global player in the field of medicines derived from human plasma. Ugo di Francesco will be the CEO of the new company, Paolo Marcucci the non-executive chairman
Althea, with over 3.000 employees managing over 1,4 million medical devices, aims to strengthen its link with hospitals.
In the last eight months, the American company has doubled in value and is now aiming to conquer the world market.
The British private equity fund will support the growth of Engel & Volkers through the digitization of the business model and the entry into markets such as the USA, Canada and the United Kingdom. Sven Odia (CEO of Engel & Völkers): “Expected revenues from…
The global private equity firm has closed its Permira VII buyout fund, reaching its maximum funding limit.
The Mexican petrochemical giant will acquire the shares held by Permira Fund, Kibbutz Magal and a part of those of Kibbutz Hatzerim - Netafim is a company founded in 1965 in Kibbutz Hatzerim, in the Negev desert, which has grown over the years to…
It is the largest investment by value made by the debt management division of Permira since the start of its operations in 2007 - The agreement signed with Soho House & Co. Limited is aimed at refinancing the company's debt and developing…